Continuing the Conversation: Treating Pregnant Women with Opioid Use Disorder (OUD)

Date: April 14, 2020 12-1PM

Featured Speaker: TBD

Note: Registering here will allow you to attend any of our future sessions. You can cancel your registration at any time.

Description: This one-hour Q & A session is a follow up to the March 10th webinar on the overview of best practices to treat patients with opioid use disorder who are also using other substances, such as stimulants, cannabis, sedatives, and other opioids. It will offer an opportunity to "continue the conversation" with Dr. Velasquez-Morfin and ask specific questions about research and practical strategies. Attendance for the first event is not required.

Continuing Medical Education and Continuing Education (CME/CE) credit offered at no cost!

For more information, contact Cfrable@mednet.ucla.edu

Co-occurring Substance Use and MOUD

Featured Speaker: Veronica Velasquez-Morfin, MD

Description: This one-hour Q & A session is a follow up to the March 10th webinar on the overview of best practices to treat patients with opioid use disorder who are also using other substances, such as stimulants, cannabis, sedatives, and other opioids. It will offer an opportunity to "continue the conversation" with Dr. Velasquez-Morfin and ask specific questions about research and practical strategies. Attendance for the first event is not required.

Continuing Medical Education and Continuing Education (CME/CE) credit offered at no cost!

 

Treating Patients with Comorbid Substance Use and Opioid Use Disorder

Featured Speaker: Veronica Velasquez-Morfin, MD

Description: This one-hour web training will provide an overview of best practices to treat patients with opioid use disorder who are also using other substances, such as stimulants, cannabis, sedatives, and other opioids. Research and practical strategies will be discussed.

 

Shared Medical Appointments for MAT Treatment

Featured Speaker: Cheryl Ho, MD

Description: This one-hour web training will provide an overview of using shared medical appointments in MAT treatment. Dr. Ho will describe the research behind this approach, the benefits, and practical steps to implement group visits in treatment settings.

   

Starting Treatment: Buprenorphine Induction 101

Featured Speaker: Candy Stockton, MD

Description: This one-hour web training will provide an overview of best practices on how to start buprenorphine treatment for opioid use disorder in a variety of settings, including hospitals, emergency department, and office-based settings. The presenter will also cover safe home induction protocols and other recommendations.

   

Demystifying DEA's Role in MAT Regulation & Implementing a Zero Risk Program

Featured Speaker: Dennis A. Wichern

Description: This one-hour web training will provide an overview of the authority of the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), and Substance Abuse and Mental Health Services Administration (SAMHSA) as it relates to regulating the use of medications in the provision of treatment for opioid use disorders (OUD), along with a review of national studies, risk mitigation strategies, case studies, emerging issues, commonly asked questions, and strategies for preventing a DEA audit. The goal of the training session is to alleviate provider concerns relative to operating a MAT medical practice.

 

Opioids as an Emergency

Featured Speaker: Aimee Moulin, MD

Description: In this one-hour webinar, Aimee Moulin, MD, frames opioid use disorder (OUD) as a medical emergency and highlights the role emergency departments and other health care providers can play in helping patients start treatment for OUD.